Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Chimeric Antigen Receptor Modified T Cells Infusion
Non-Hodgkin Lymphoma
Shanxi Bethune Hospital
N/A
D
(30)
Chimeric Antigen Receptor Modified T Cells Infusion
Plasma Cell Myeloma
Shanxi Bethune Hospital
N/A
D
(30)
Claudin18.2 Car-T Cells
Gastric Carcinoma
Shenzhen University General Hospital
N/A
D
(30)
Cord Blood Red Blood Cells
Neonatal Anemia
Hospital Clinic of Barcelona
N/A
D
(30)
Cord Blood Red Blood Cells
Bronchopulmonary Dysplasia
Hospital Clinic of Barcelona
N/A
D
(30)
Cord Blood Red Blood Cells
Hereditary Persistence Of Fetal Hemoglobin
Hospital Clinic of Barcelona
N/A
D
(30)
Cord Blood Red Blood Cells
Retinopathy Of Prematurity
Hospital Clinic of Barcelona
N/A
D
(30)
ct0590 car t cells
Plasma Cell Myeloma
The First Affiliated Hospital of Soochow University
N/A
D
(30)
ct0594cp
Plasma Cell Leukemia
The First Affiliated Hospital of Soochow University
N/A
D
(30)
gt316
Female Reproductive System Neoplasm
Grit Biotechnology
N/A
D
(30)
her2-e-cart cells
Neoplasm
su haichuan
N/A
D
(30)
Showing 2626 to 2650 of 3,186 assets
Previous
Page 106 of 128
Next